The Chemosensitivity Profile of Retinoblastoma

Anti-Cancer Drugs - United States
doi 10.1097/00001813-200109000-00021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)